PART 2: Yuval Shaked, ASCO 2020: Host Response Profiling for Melanoma Patients

Original source here

We were joined by Professor Yuval Shaked (Technion – Israel Institute of Technology) to discuss the abstract presented at the ASCO20 Virtual Meeting on the use of advanced bioinformatic analysis and machine learning tools on plasma proteomics in order to predict outcomes of immunotherapy-treated melanoma patients.

To view PART 1 click here: https://youtu.be/JbESlC0VtTg

Questions

1. What were the main study findings and what have they taught us about the mechanisms of resistance to immunotherapy? (0:06)
2. How will these proteomic data be used to harness host response to better predict clinical outcomes? (3:51)

Speaker disclosure: Yuval Shaked is Co-founder and Chief Scientific Advisor for OncoHost. Support: Interview and filming supported by Touch Medical Media.

Commissioned in liaison with FINN Partners. Filmed in coverage of the 2020 ASCO Virtual Scientific Program.